Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell types

The FEBS Journal
Cristina CecchiMassimo Stefani

Abstract

Considerable attention has been paid to the high cytotoxic potential of small, prefibrillar aggregates of proteins/peptides, either associated or not associated with amyloid diseases. Recently, we reported that different cell types are variously affected by early aggregates of the N-terminal domain of the prokaryotic hydrogenase maturation factor HypF (HypF-N), a protein not involved in any disease. In this study, we provide detailed information on a chain of events triggered in Hend murine endothelial cells and IMR90 fibroblasts, which have previously been shown to be highly vulnerable or very resistant, respectively, to HypF-N aggregates. Initially, both cell lines displayed impaired viability upon exposure to HypF-N toxic aggregates; however, at longer exposure times, IMR90 cells recovered completely, whereas Hend cells did not. In particular, significant initial mitochondrial permeability transition (MPT) pore opening was found in IMR90 cells followed by a sudden repair of membrane integrity with rapid and efficient inhibition of cytochrome c and AIF release, and upregulation of Bcl-2. The greater resistance of IMR90 fibroblasts may also be due to a higher cholesterol content in the plasma membrane, which disfavours interac...Continue Reading

References

Oct 1, 1995·Trends in Biochemical Sciences·T LindahlA Klungland
Jan 26, 1996·The Journal of Biological Chemistry·T A MirzabekovB L Kagan
Nov 1, 1995·Neurochemical Research·K WellsL A Horrocks
Oct 1, 1996·The Journal of Experimental Medicine·S A SusinG Kroemer
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·F ChitiC M Dobson
Aug 24, 2001·Journal of Molecular Biology·C M YipJ McLaurin
Aug 30, 2001·Experimental Gerontology·T C Squier
Oct 10, 2001·Journal of Neuroscience Research·J I KourieC L Henry
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H LinR Lal
Jun 18, 2002·Journal of Neurochemistry·Richard Dargusch, David Schubert
Jul 11, 2002·Cell Death and Differentiation·B L SchwabP Nicotera
Aug 8, 2002·Clinical and Experimental Pharmacology & Physiology·Joseph I Kourie, Christine L Henry
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Carlos Velez-PardoMarlene Jimenez Del Rio
Jul 3, 2003·Nature Reviews. Molecular Cell Biology·Sten OrreniusPierluigi Nicotera
Aug 28, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Massimo Stefani, Christopher M Dobson
Sep 23, 2003·Journal of Molecular Neuroscience : MN·Shyamala MruthintiJerry J Buccafusco
Jan 24, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J EmeritF Bricaire
Mar 24, 2004·Seminars in Cell & Developmental Biology·Christopher M Dobson
Apr 8, 2004·Proceedings of the National Academy of Sciences of the United States of America·Koichi IijimaYi Zhong
May 11, 2004·The Journal of Biological Chemistry·Monica BucciantiniMassimo Stefani
Jun 3, 2004·The Journal of Biological Chemistry·Kakulavarapu V Rama Rao, Michael D Norenberg
Oct 16, 2004·The Journal of Investigative Dermatology·Sandra FrankBernard Coulomb
Dec 18, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Monica BucciantiniMassimo Stefani
Jan 15, 2005·Biochemical Society Symposium·Maria Dolores Ledesma, Carlos G Dotti
Feb 22, 2005·The Journal of Biological Chemistry·Angelo DemuroCharles G Glabe
Aug 2, 2005·Biochimica Et Biophysica Acta·Laurent M DejeanKathleen W Kinnally

❮ Previous
Next ❯

Citations

Nov 15, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sofia GiorgettiVittorio Bellotti
Apr 26, 2007·Annals of Medicine·Vittorio BellottiGiampaolo Merlini
Dec 16, 2010·Journal of Cellular and Molecular Medicine·Mariagioia ZampagniCristina Cecchi
Jan 16, 2007·Biochemical and Biophysical Research Communications·K Hun MokCatharina Svanborg
Apr 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Serene W ChenNunilo Cremades
Apr 23, 2013·Neurobiology of Aging·Francesca TatiniFabrizio Chiti
Jun 21, 2012·The International Journal of Biochemistry & Cell Biology·Gaetano InvernizziSalvador Ventura
Dec 28, 2006·Neurochemical Research·Vittorio CalabreseAnnamaria Giuffrida Stella
Oct 22, 2020·Scientific Reports·Maria Ylenia FarrugiaNeville Vassallo

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.